Pediatric Atypical Antipsychotic Outpatient Drug Utilization in the US: Y2002-Y2009

被引：0
|
作者：
Chai, Grace P. [1 ]
Mehta, Hina [1 ]
Governale, Laura [1 ]
机构：
[1] US FDA, Off Surveillance & Epidemiol, Silver Spring, MD USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2010年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
668
引用
收藏
页码：S282 / S283
页数：2
相关论文
共 43 条
  • [1] Pediatric Antiretroviral Outpatient Drug Utilization in the US: Y2002-Y2010
    Chang, Stephen H.
    Shih, David C.
    Tracy Pham
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S91 - S92
  • [2] Trends in Outpatient Drug Utilization Patterns in the US Pediatric Population: Y2002-Y2008
    Greene, Patty
    Governale, Laura
    Borders-Hemphill, Vicky
    Mehta, Hina
    Moeny, David
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 : S57 - S57
  • [3] Neuropharmacological profile of a novel potential atypical antipsychotic drug Y-931
    Kuriyama, M
    Hashimoto, K
    Morimoto, T
    Tanaka, H
    Fujimura, M
    Kimura, K
    Takehara, S
    Yasumatsu, H
    Yamagami, K
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2002, 17 : S107 - S108
  • [4] Trends of Outpatient Prescription Drug Utilization in US Children, 2002-2010
    Chai, Grace
    Governale, Laura
    McMahon, Ann W.
    Trinidad, James Phillip
    Staffa, Judy
    Murphy, Dianne
    PEDIATRICS, 2012, 130 (01) : 23 - 31
  • [5] Y-931, a novel atypical antipsychotic drug, is less sensitive to oxidative phenomena
    Kohara, T
    Koyama, T
    Fujimura, M
    Tanaka, H
    Maeda, A
    Fujimoto, T
    Yamamoto, I
    Arita, M
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2002, 50 (06) : 818 - 821
  • [6] Effect of a novel potential atypical antipsychotic drug, Y-931, in producing dystonia in Cebus monkeys
    Shiigi, Y
    Maeda, JI
    Yasumatsu, H
    Tanaka, H
    Casey, DE
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2003, 93 (03) : 364 - 366
  • [7] Recent US Drug Utilization For Pediatric Inflammatory Bowel Disease, 2009-2015
    Hall, Susan A.
    Viscidi, Emma W.
    Allen, Jeff K.
    Juneja, Maneesh
    Eaton, Susan
    Cook, Suzanne F.
    Dilley, Anne B.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 65 - 66
  • [8] Comparison of pediatric atypical antipsychotic exposures reported to US poison centers
    Stassinos, Gina
    Klein-Schwartz, Wendy
    CLINICAL TOXICOLOGY, 2017, 55 (01) : 40 - 45
  • [9] PHARMACOKINETIC STUDY OF CLOCAPRAMINE AND Y-516, ATYPICAL ANTIPSYCHOTIC-DRUGS
    ISHIGOOKA, J
    MURASAKI, M
    WAKATABE, H
    ISHII, Y
    MIURA, S
    ACTA PHARMACOLOGICA ET TOXICOLOGICA, 1986, 59 : 107 - 107
  • [10] Proton Pump Inhibitor use in the US Outpatient Setting, 2002-2009
    Rotman, Stephen R.
    Bishop, Tara F.
    GASTROENTEROLOGY, 2012, 142 (05) : S396 - S396
12345